- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Invictus MD's Chairman and CEO Granted Stock Options
VANCOUVER, BC / TheNewswire / March 9, 2017 – Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS).
VANCOUVER, BC / TheNewswire / March 9, 2017 – Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS).
Mr. Dan Kriznic, director of Invictus MD Strategies Corp. (the “Issuer”), announces that on March 2, 2017, he was granted stock options (the “Options”) to purchase 1,000,000 common shares of the Issuer exercisable at a price of $1.75 per common share on or before March 2, 2022.
Prior to the grant of Options, Mr. Kriznic had ownership and control, directly and indirectly, of 2,308,204 common shares, 85,000 warrants and 1,555,000 stock options of the Issuer, representing approximately 6.07% of the issued and outstanding common shares of the Issuer on a non-diluted basis and approximately 9.96% of the issued and outstanding common shares of the Issuer when assuming exercise of all 85,000 warrants and 1,555,000 stock options held by Mr. Kriznic.
Immediately after the grant of Options, Mr. Kriznic had ownership and control, directly and indirectly, of 2,308,204 common shares, 85,000 warrants and 2,555,000 stock options of the Issuer, representing approximately 6.07% of the issued and outstanding common shares of the Issuer on a non-diluted basis and approximately 12.17% of the issued and outstanding common shares of the Issuer when assuming exercise of all 85,000 warrants and 2,555,000 stock options held by Mr. Kriznic.
A copy of the early warning report in respect of the foregoing matters has been filed under the Issuer’s profile on the System for Electronic Document Analysis and Review (SEDAR) at www.sedar.com. You may also contact Dan Kriznic, Chairman & CEO of the Issuer, in order to obtain a copy of the early warning report at Suite 3123 – 595 Burrard Street, PO Box 49139, Three Bentall Centre, Vancouver, BC V7X 1J1 or at (604) 368-6437.
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on three main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR; Fertilizer and Nutrients through Future Harvest Development Ltd.; and Cannabis Data and Delivery, with its wholly owned subsidiary Poda Technologies Ltd.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,
Dan Kriznic
Chairman & CEO
604-368-6437
Larry Heinzlmeir
Vice President, Marketing & Communications
604-537-8676
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.